Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus

Name: Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
License: Public Domain

Novo Nordisk A/S

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes diabetes-mellitus type-2

diabetes, diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 234370
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.